ImmunoACT (@actimmuno) 's Twitter Profile
ImmunoACT

@actimmuno

Pioneers of India's first commercially available CAR-T cell therapy. - NexCAR19, powered by indigenously integrated genetic engineering for a healthier tomorrow

ID: 1404706950919561218

linkhttp://immunoact.com/ calendar_today15-06-2021 07:47:02

228 Tweet

1,1K Takipçi

36 Takip Edilen

ImmunoACT (@actimmuno) 's Twitter Profile Photo
ImmunoACT
@actimmuno

a year ago

With over 150 infusions of #NexCAR19 in India so far, we are continuously engaging with the haemato-oncology community in ensuring that #CARTcelltherapy is accessible, affordable, and a viable treatment option in the management of refractory/relapsing B-ALL and B-cell Lymphomas.

With over 150 infusions of #NexCAR19 in India so far, we are continuously engaging with the haemato-oncology community in ensuring that #CARTcelltherapy is accessible, affordable, and a viable treatment option in the management of refractory/relapsing B-ALL and B-cell Lymphomas.